Marketing - Press Releases

Date	Title	Company
31-Oct-2019	Aenitis Technologies and the Direction Générale de l'Armement (DGA) sign a partnership to develop a new AMSC-S project with a 1,2 million euros budget	AENITIS TECHNOLOGIES
31-Oct-2019	Biophytis Files Protocol Amendment to Optimize the SARA-INT Phase 2b Clinical Trial for Sarcopenia	Biophytis SA
31-Oct-2019	Bulletin from Moberg Pharma’s AGM on October 30th , 2019	Moberg Pharma
31-Oct-2019	Harley Street clinics to offer new brain stimulation treatment for depression	Flow Neuroscience
31-Oct-2019	First NHS patient receives Chiesi’s advanced-therapy-medicinal product, Holoclar▼ for moderate-to-severe limbal stem cell deficiency (LSCD) caused by chemical or thermal eye burns	Chiesi UK
31-Oct-2019	Investigational Ebola Vaccine from Janssen and Bavarian Nordic to Support Outbreak Response in Democratic Republic of the Congo	Bavarian Nordic A/S
31-Oct-2019	Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health	NEX China 2020
30-Oct-2019	ProteoGenix Launches New Human and Rabbit Antibody Libraries to Speed Up the Discovery of Better Therapeutic and Analytical Antibodies	ProteoGenix
30-Oct-2019	Navigating the Globalisation of Clinical Trials	Medidata
30-Oct-2019	MultiTEP Platform-Based Epitope Vaccine Targeting the Phosphatase Activating Domain (PAD) of Tau Shows Clear Therapeutic Efficacy in PS19 Mice	Capo Therapeutics, Inc
30-Oct-2019	Sanifit announces that the Phase 2b CaLIPSO trial of SNF472 met its primary endpoint in slowing the progression of cardiovascular calcification in patients on hemodialysis Top line data to be presented at 2019 Scientific Sessions of American Heart Association	Sanifit
30-Oct-2019	New ImpactAir ISO-90 microbial air sampler	CHERWELL LABORATORIES
30-Oct-2019	Dupixent® (dupilumab) now approved in European Union for severe chronic rhinosinusitis with nasal polyposis	Regeneron
29-Oct-2019	PharmiWeb To Launch In Australia	PharmiWeb.Jobs
29-Oct-2019	Upperton continues to invest in key equipment to support expansion of its solid dosage form capabilities and CDMO services	Upperton Pharma Solutions
29-Oct-2019	PredictImmune announces a strategic agreement with Theradiag for French speaking Europe to commercialise PredictSURE IBD™, the world’s first validated prognostic test for inflammatory bowel disease	PredictImmune
29-Oct-2019	APX3330 Phase I Oncology Trial Presented at AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting	Apexian Pharmaceuticals
29-Oct-2019	Mobidiag signs new international agreements for distribution of its Amplidiag® and Novodiag® diagnostic solutions Agreements signed in Poland, Ukraine, Romania and Israel, with more in discussions.	Mobidiag Ltd
29-Oct-2019	Sense Biodetection Raises £12.3m to Progress Instrument-Free Molecular Diagnostics	Sense Biodetection Limited
29-Oct-2019	Polyplus-transfection(R) adds to transfection reagent portfolio for vaccination and cancer research	Polyplus-transfection(R) SA